Empirica Signal: Market Health | Sep 28, 2026 ·
This week's reading: hold fresh money, build the watchlist
Read moreEmpirica researches Indian small and midcaps in the ₹2,000–30,000 crore band, the window where price action has started but coverage has not.
You get the full reasoning: the entry, the stop, the risks we found, and the ones we are still watching.
India has no shortage of stock ideas. What it lacks is reasoning you can inspect: the working behind the call, the price that would prove it wrong, and an honest record of the ones that did.
We built Empirica the other way round. Every company we cover gets a 60 to 80 page institutional-grade report: the balance sheet, the promoter pledge, the transcript contradictions, the entry zone, the stop loss. We publish the risks before we publish the case. And when a position fails, it stays on the record.
We are not a brokerage. We earn nothing from your trades, nothing from any AMC, and nothing from volume. We are paid by readers, which means the only thing we have to sell is being right.
Read more“We would rather be early and boring than late and loud.”
— The principles that guide every Empirica portfolio.
Three core products
Most services hand you a name and leave you alone with it. You get the whole chain instead: the companies still on the bench, the analysis that promoted or rejected each one, and the position with its size and exit already defined.
Eight to twelve companies with live charts, on the page while the work is still underway. You start from a screened shortlist in ₹2,000 to 30,000 cr marketcap territory instead of hunting for ideas alone.
Free Newsletter: Signal teaches our framework every week. Paid Newsletter: Selection covers what entered our watchlist and why. Paid Newsletter: Positioning is the full research report. You learn to judge a call rather than simply receive one.
Position sizes, entry dates, exits and stop loss levels published in paid subscription. You see what we did and the level at which we would be wrong, so you can size it against your own money instead of guessing.
The watchlist and the weekly letter are free, permanently. The reports and the portfolio are what a subscription buys.
See what each plan includes →The Ignition Framework
Every company we cover goes through the same sequence. Most do not survive step two, and that is the point of having a sequence at all.
We screen on relative strength against the NSE 500 across 1, 3, 6 and 12 months. The market speaks before the research does.
Only names that clear the screen get the fundamental work. Most fail here, and that is exactly what the step is for.
Promoter pledge, transcript against filing, FII and DII holding patterns. The uncomfortable finding is usually the valuable one.
A technical seven-point checklist with an explicit pass or fail, an entry zone, position sizing and stop loss at which we admit we were wrong.
Companies in the ₹2,000–30,000 crore band only. Below that, liquidity fails you. Above it, the research has already arrived.
See what is in the framework right now →Two positions are open below with the full history visible. Paid subscribers get the full list of holdings, average prices and XIRR.
Every plan includes the weekly Signal and the live watchlist. What changes is how much of our work you see.
Learn how to find investment ideas, position building, entry & exit strategies in the Indian markets. If you are new to the markets this is for you.
This plan aids you in becoming an informed investor. In addition get a monthly research report on one of the ideas in which we have been investing @Empirica India
Get full access to model portfolio @ Empirica India. This includes our position sizing, exact buy and sell dates for each investment call. This is a full package to get to know our investment strategy and execution @ Empirica India
Company deep dives, framework notes and market reads.
This week's reading: hold fresh money, build the watchlist
Read more
The largest maker of corrosion-proof process equipment in the world spent three years going nowhere. Sales stopped growing. Reported profit fell by more than three quarters. The share price halved. Underneath all of that, the company was quietly generating more spare cash every single year ₹367 crore last year against ₹52 crore of reported profit. Its order book has just reached an all-time high, and the share price has broken out to a new high.
Read more
EMPIRICA INDIA | SELECTION · Watchlist addition · 18 September 2026
Read moreOur views matter & listened by top editors of the nation
Join free and you get the weekly Signal, the live watchlist and the framework we use. No card, and nothing changes until you decide it should.
Create your account